EP 2099800 A1 20090916 - 7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION
Title (en)
7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION
Title (de)
7-SUBSTITUIERTE PURINDERIVATE ZUR IMMUNSUPRESSION
Title (fr)
DÉRIVÉS DE PURINE SUBSTITUÉS EN 7, DESTINÉS À L'IMMUNOSUPPRESSION
Publication
Application
Priority
US 2006061004 W 20061116
Abstract (en)
[origin: WO2008060301A1] The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula (III).
IPC 8 full level
C07D 487/04 (2006.01); A61K 31/522 (2006.01); A61P 37/06 (2006.01); C07D 519/00 (2006.01)
CPC (source: EP KR)
A61K 31/522 (2013.01 - KR); A61P 11/06 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 487/04 (2013.01 - EP KR); C07D 519/00 (2013.01 - KR)
Citation (search report)
See references of WO 2008060301A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2008060301 A1 20080522; AU 2006350748 A1 20080522; AU 2006350748 A2 20090806; BR PI0622030 A2 20140422; CA 2669686 A1 20080522; CN 101595110 A 20091202; CR 10870 A 20091201; EP 2099800 A1 20090916; IL 198761 A0 20100217; JP 2010510211 A 20100402; KR 20100014271 A 20100210; MX 2009005194 A 20091110
DOCDB simple family (application)
US 2006061004 W 20061116; AU 2006350748 A 20061116; BR PI0622030 A 20061116; CA 2669686 A 20061116; CN 200680056775 A 20061116; CR 10870 A 20090616; EP 06850161 A 20061116; IL 19876109 A 20090514; JP 2009537135 A 20061116; KR 20097012508 A 20061116; MX 2009005194 A 20061116